MedTrace Logo

Telemedicine Clinic for Prostate Cancer Patients

NCT03413865 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2019-02-15

No results posted yet for this study

Summary

This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.

Conditions

  • Cancer, Treatment-Related

Interventions

OTHER

Visits conducted via Telemedicine

Patients will be followed via telemedicine with visits lead by a Pharmacist and a Nurse

Sponsors & Collaborators

  • Grand River Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-28
Primary Completion
2020-10-31
Completion
2021-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413865 on ClinicalTrials.gov